Loading clinical trials...
Loading clinical trials...
To examine antihypertensive effect and safety of administration of CS-3150 in patients with severe hypertension (Grade III).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Daiichi Sankyo Co., Ltd.
NCT07511361 · Hypertension, Acute Severe Hypertension
NCT00307060 · Mild to Severe Hypertension
Sapporo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions